Evidence map›Paper›PMID 36967100›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2023

Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis.

Girish Hiremath, Lili Sun, Margaret H Collins, Peter A Bonis, Nicoleta C Arva, Kelley E Capocelli, Mirna Chehade, Carla M Davis, Gary W Falk, Nirmala Gonsalves and 14 more

Abstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Quality indicators for upper GI endoscopy.Gastrointestinal endoscopy · 2025
    Guideline
  3. Quality Indicators for Upper GI Endoscopy.The American journal of gastroenterology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Girish HiremathDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: Girish.Hiremath@vumc.org.
Lili SunDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Margaret H CollinsDepartment of Pathology and Laboratory Medicine, Cincinnati Children's Hospital, Cincinnati, Ohio.
Peter A BonisDivision of Gastroenterology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts.
Nicoleta C ArvaDepartment of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital at Chicago, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Kelley E CapocelliDepartment of Pathology, Children's Hospital Colorado, Aurora, Colorado.
Mirna ChehadeMount Sinai Center for Eosinophilic Disorders, Icahn School of Medicine at Mount Sinai, New York, New York.
Carla M DavisImmunology, Allergy, and Retrovirology Division, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.
Gary W FalkDivision of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Nirmala GonsalvesDivision of Gastroenterology and Hepatology, Northwestern Medicine, Chicago, Illinois.
Sandeep K GuptaDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine, Indianapolis, Indiana.
Ikuo HiranoDivision of Gastroenterology and Hepatology, Northwestern Medicine, Chicago, Illinois.
John LeungBoston Specialists/Boston Food Allergy Center, Boston, Massachusetts.
Paneez KhouryNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Vincent A MukkadaGastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine Department of Pediatrics, Cincinnati, Ohio.
Lisa J MartinDivision of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Jonathan M SpergelDivision of Allergy-Immunology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Pennsylvania.
Joshua B WechslerDivision of Pediatric Gastroenterology, Hepatology, and Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
Guang-Yu YangDivision of Anatomical Pathology, Northwestern Feinberg School of Medicine, Chicago, Illinois.
Seema S AcevesDivision of Rheumatology, Allergy & Immunology, Rady Children's Hospital, San Diego, San Diego, California.
Glenn T FurutaSection of Pediatric Gastroenterology and Hepatology, Gastrointestinal Eosinophilic Diseases Program, Children's Hospital Colorado, University of Colorado School of Medicine, Colorado.
Marc E RothenbergDivision of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, University of Cincinnati College of Medicine, Ohio.
Tatsuki KoyamaDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
Evan S DellonDivision of Gastroenterology and Hepatology, the University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.

Funding

The Impact of COVID-19 on People Living with Rare Diseases and Their FamiliesU2CTR002818 · NCATS · CINCINNATI CHILDRENS HOSP MED CTR · PI Maurizio Macaluso · 2019 to 2026
$51.2M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
TRAINING (CAREER DEVELOPMENT) COMPONENTU54AI117804 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI GLENN T FURUTA, Marc E. Rothenberg · 2014 to 2026
$18.5M
Precision Medicine Approaches for Eosinophilic Esophagitis Using Raman Spectroscopy and Machine LearningK23DK131341 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HIREMATH, GIRISH · 2022 to 2025
$688k
NCATS NIH HHS U2C TR002818NIAID NIH HHS U54 AI117804NIDDK NIH HHS K23 DK131341NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

BACKGROUND &

aimsThe nature of the involvement of esophageal tissue in eosinophilic esophagitis (EoE) is unclear. We estimated the intrabiopsy site agreements of the EoE Histologic Scoring System (EoEHSS) scores for the grade (degree) and stage (extent) of involvement of the esophageal epithelial and lamina propria and examined if the EoE activity status influenced the intrabiopsy site agreement.

methodsDemographic, clinical, and EoEHSS scores collected as part of the prospective Outcome Measures for Eosinophilic Gastrointestinal Diseases Across Ages study were analyzed. A weighted Cohen's kappa agreement coefficient (k) was used to calculate the pairwise agreements for proximal:distal, proximal:middle, and middle:distal esophageal biopsy sites, separately for grade and stage scores, for each of the 8 components of EoEHSS. A k > 0.75 was considered uniform involvement. Inactive EoE was defined as fewer than 15 eosinophils per high-powered field.

resultsEoEHSS scores from 1263 esophageal biopsy specimens were analyzed. The k for the stage of involvement of the dilated intercellular spaces across all 3 sites in inactive EoE was consistently greater than 0.75 (range, 0.87-0.99). The k for lamina propria fibrosis was greater than 0.75 across some of the biopsy sites but not across all 3. Otherwise, the k for all other features, for both grade and stage, irrespective of the disease activity status, was 0.75 or less (range, 0.00-0.74).

conclusionsExcept for the extent of involvement of dilated intercellular spaces in inactive EoE, the remaining epithelial features and lamina propria are involved unevenly across biopsy sites in EoE, irrespective of the disease activity status. This study enhances our understanding of the effects of EoE on esophageal tissue pathology.

Indexed as

Eosinophilic EsophagitisBiopsyEnteritisEosinophiliaEosinophilsEpitheliumGastritisHumansMucous MembraneProspective StudiesEosinophilic EsophagitisEpithelial AlterationsHistology Scoring SystemLamina Propria FibrosisPeak Eosinophil Counts

Identifiers

PMID36967100
PMCPMC10518022

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.